Detection of c-fos expression in benign and malignant musculoskeletal lesions

Journal of Orthopaedic Research

Volumn 19, Issue 3, 2001, Pages 339-345

  Weisstein, Jason S ^a   Majeska, Robert J ^b   Klein, Michael J ^b   Einhorn, Thomas A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELLS; DISEASES; GENES; PATHOLOGY; RNA; TUMORS;

LESIONS;

ORTHOPEDICS;

MESSENGER RNA; PROTEIN C FOS;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; BONE TUMOR; CANCER GRADING; CARTILAGE TUMOR; CHILD; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMATOSIS; FIBROSARCOMA; FIBROUS DYSPLASIA; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT NEOPLASTIC DISEASE; MUSCULOSKELETAL DISEASE; OSTEOSARCOMA; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTO ONCOGENE; RNA TRANSCRIPTION; TISSUE; TRANSGENIC MOUSE;

EID: 0035023776     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(00)90020-2     Document Type: Article

References (41)

1. Angel P., Karin M. The role of jun, fos, and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta. 1072:1991;129-157.
2. Barrios C., Castresana J.S., Ruis J., Kreicbergs A. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma. J Orthop Res. 11:1993;556-563.
3. Bogenmann E., Moghadam H., DeClerck Y.A., Mock A. c-Myc amplification and expression in newly established human osteosarcoma cell lines. Cancer Res. 47:1987;3808-3814.
4. Candeliere G.A., Glorieux F.H., Prud'homme J., St.-Arnaud R. Increased expression of the c-fos proto-oncogene in bone marrow from patients with fibrous dysplasia. N Engl J Med. 332:1995;1546-1551.
5. Castresana J.S., Barrios C., Gomez L., Kreicbergs A. Amplification of the c-myc proto-oncogene in human chondrosarcoma. Diagn Mol Pathol. 1:1992;235-238.
6. Chung K.Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for regulation of the human. α 2(I) collagen (COL1A2) promoter activity by transforming growth factor- β J Biol Chem. 271:1996;3272-3278.
7. Clohisy J.C., Scott D.K., Brakenhoff K.D., Quinn C.O., Partridge N.C. Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells. Mol Endocrinol. 6:1992;1834-1842.
8. Crabb I.D., Hughes S.S., Hicks D.G., Puzas J.E., Tsao G.J.Y., Rosier R.N. Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Am J Pathol. 141:1992;579-589.
9. Finkel J.P., Biskis B.O., Jinkins P.B. Virus induction of osteosarcomas in mice. Science. 151:1966;698-701.
10. Finkel JP, Reilly Jr CA, Biskis BO. Viral etiology of bone cancer. Front Radiat Ther Oncol 1975;10:28-39.
11. Franchi A., Calzolari A., Zampi G. Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumors of the skeleton. Virchows Arch. 432:1998;515-519.
12. Gamberi G., Benassi M.S., Bohling T., Ragazzini P., Molendini L., Sollazzo M.R.et al. c-Myc and c-fos in human osteosarcoma: prognostic value of m-RNA and protein expression. Oncology. 55:1998;556-563.
13. Greenberg M.E., Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 311:1984;433-438.
14. Grigoriadis A.E., Schellander K., Wang Z.Q., Wagner E.F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol. 122:1993;685-701.
15. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A.et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 266:1994;443-448.
16. Haase M., Koslowski R., Lengnick A., Hahn R., Wenzel K.W., Schuh D.et al. Cellular distribution of c-jun and c-fos in rat lung before and after bleomycin induced injury. Virchows Arch. 431:1997;441-448.
17. Honoki K., Tsutsumi M., Toshifumi T., Kondoh S., Shiraiwa K., Miyauchi Y.et al. Expression of the transin, c-fos, and c-jun genes in rat transplantable osteosarcomas and malignant fibrous histiocytomas. Mol Carcinog. 6:1992;122-128.
18. Hoyland J., Sharpe P.T. Upregulation of c-fos protoncogene expression in pagetic osteoclasts. J Bone Miner Res. 9:1994;1191-1194.
19. Ikeda S., Sumii H., Akiyama K., Watanabe S., Ito S., Inoue H.et al. Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma. Jpn J Cancer Res. 80:1989;6-9.
20. Krontiris T.G. Oncogenes. N Eng J Med. 333:1995;303-306.
21. Labelle Y., Bussieres J., Courjal F., Goldring M.B. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene. 18:1999;3303-3308.
22. Lee K., Deeds J.D., Chiba S., Masako U., Bond A.T., Segre G.V. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology. 134:1994;441-450.
23. Naka T., Iwamoto Y., Shinohara N., Ushijima M., Chuman H., Tsuneyoshi M. Expression of c-met proto-oncogene product (c-met) in benign and malignant bone tumors. Mod Pathol. 10:1997;832-838.
24. Ohta S., Yamamuro T., Lee K., Okumura H., Kasai R., Hiraki Y.et al. Fracture healing induces expression of the proto-oncogene c-fos in vivo. FEBS Lett. 284:1991;42-45.
25. Pearman A.T., Chou W.Y., Bergman K.D., Pulumati M.R., Partridge N.C. Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE. J Biol Chem. 271:1996;25715-25721.
26. Pompetti F., Rizzo P., Simon R.M., Fredlin B., Mew D.J., Pass H.I.et al. Oncogene alterations in primary recurrent and metastatic bone tumors. J Cell Biochem. 63:1996;37-50.
27. Ruther U., Garber C., Komitowski D., Muller R., Wagner E.F. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature. 325:1987;412-416.
28. Ruther U., Komitowski D., Schubert F.R., Wagner E.F. c-Fos expression induces bone tumors in transgenic mice. Oncogene. 4:1989;861-865.
29. Sandberg M., Vuorio T., Hirvonen H., Alitalo K., Vuorio E. Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development. 102:1988;461-470.
30. Schon A., Michiels L., Janowski M., Merregaert J., Erfle V. Expression of protooncogenes in murine osteosarcomas. Int J Cancer. 38:1986;67-74.
31. Silver J., Mohaideen A., Atkinson G., Einhorn T.A., Majeska R.J. Expression of c-fos mRNA during fracture healing in the rat. Trans Orthop Res Soc. 22:1997;606.
32. Sunters A., McCluskey J., Grigoriadis A.E. Control of cell cycle gene expression in bone development and during c-fos-induced osteosarcoma formation. Dev Genet. 22:1998;386-397.
33. Teofoli P., Barduagni S., Ribuffo M., Campanella A., De Pita O., Puddu P. Expression of bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci. 22:1999;31-37.
34. Wang H., Rodgers W.H., Chmell M.J., Svitek C., Schwartz H. Osteosarcoma oncogene expression detected by in situ hybridization. J Orthop Res. 13:1995;671-678.
35. Wang Z.Q., Grigoriadis A.E., Mohle-Steinlein U., Wagner E.F. A novel target cell for c-fos induced oncogenesis: development of chondrogenic tumors in embryonic stem cell chimeras. EMBO J. 10:1991;2437-2450.
36. Wang Z.Q., Grigoriadis A.E., Wagner E.F. Stable murine chondrogenic cell lines derived from c-fos induced cartilage tumors. J Bone Miner Res. 8:1993;839-847.
37. Wang Z.Q., Liang J., Schellander K., Wagner E.F., Grigoriadis A.E. c-Fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Res. 55:1995;6244-6251.
38. Ward J.M., Young D. Histogenesis and morphology of periosteal sarcomas induced by FBJ virus in NIH Swiss mice. Cancer Res. 36:1976;3985-3992.
39. Wu J.X., Carpenter P.M., Gresens C., Keh R., Morris J.W.S., Mercola D. The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene. 5:1990;989-1000.
40. Yabut S.M., Kenan S., Sissons H.A., Lewis M.M. Malignant transformation of fibrous dysplasia: a case report and review of the literature. Clin Orthop. 228:1988;281-289.
41. Zhu J.D., Pan H.O., Suzuki F., Takigawa M. Proto-oncogene expression in a human chondrosarcoma cell line: HCS-2/8. Jpn J Cancer Res. 85:1994;364-371.